Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 21.2.2025Baxalta Innovations GmbH (BXA)85677FEIBA 50 U/ml (plv iio 1x1000 U+20 ml solv.(liek.inj.skl.+prísl.))20.2.2025Z
 20.2.2025MEDOCHEMIE Ltd. (MOE)65114MEDOCLAV 1,2 g (plo ijf 100x1,2 g (liek.inj.skl.))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)65111MEDOCLAV 1,2 g (plo ijf 10x1,2 g (liek.inj.skl.))17.2.2025R
 20.2.2025MEDOCHEMIE Ltd. (MOE)0849EJIDINUM 100 mg filmom obalené tablety (tbl flm 98x100 mg (blis.PA/Al/PVC/Al))17.2.2025R
 20.2.2025MEDOCHEMIE Ltd. (MOE)67525ANARGIL 100 mg (cps dur 100x100 mg (blis.PVC/Al))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)67563Dapril 20 mg (tbl 20x20 mg (blis.PVC/PVDC/Al))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)39638ALMIRAL GEL (gel 1x100 g (tuba Al))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)67520MEDOCIPRIN 500 mg (tbl flm 10x500 mg (blis.PVC/Al))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)40200KLERIMED 250 mg (tbl flm 14x250 mg (blis.PVC/PVDC/Al))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)40203KLERIMED 500 mg (tbl flm 14x500 mg (blis.PVC/PVDC/Al))17.2.2025R
 20.2.2025MEDOCHEMIE Ltd. (MOE)67031MEDOFLUCON 150 mg (cps dur 10x150 mg (blis.PVC/Al))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)67563Dapril 20 mg (tbl 20x20 mg (blis.PVC/PVDC/Al))20.2.2025R
 20.2.2025MEDOCHEMIE Ltd. (MOE)67517MEDOCIPRIN 250 mg (tbl flm 10x250 mg (blis.PVC/Al))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)34922MEDOFLOXINE 200 mg (tbl flm 20x200 mg (blis.PVC/Al))17.2.2025R
 20.2.2025MEDOCHEMIE Ltd. (MOE)33199MEDOFLUCON 50 mg (cps dur 100x50 mg (blis.PVC/Al))17.2.2025O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)